34 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
25971770	10	Progress in discovery of small-molecule modulators of protein-protein interactions via fragment screening.	Pfizer
24266771	3	Bisphenol A binds to Ras proteins and competes with guanine nucleotide exchange: implications for GTPase-selective antagonists.	Ruhr University of Bochum
23566315	3	Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators.	The University of Arizona
21381769	56	Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery.	Universite£
32276831	10	Chalcones bearing a 3,4,5-trimethoxyphenyl motif are capable of selectively inhibiting oncogenic K-Ras signaling.	Wright State University
32250617	27	Identification of the Clinical Development Candidate	Array Biopharma
32023060	19	Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRAS	Astrazeneca
30655937	10	Inhibitors of G12C Mutant Ras Proteins for the Treatment of Cancers.	Usona Institute
31706640	5	Selective apoptosis-inducing activity of synthetic hydrocarbon-stapled SOS1 helix with d-amino acids in H358 cancer cells expressing KRAS	China Pharmaceutical University
31620220	11	Inhibitors of KRAS May Potentially Provide Effective Cancer Treatment.	Therachem Research Medilab
31531201	37	Discovery of	Amgen
31820981	62	Discovery of a Covalent Inhibitor of KRAS	TBA
30613331	14	Discovery of Tetrahydropyridopyrimidines as Irreversible Covalent Inhibitors of KRAS-G12C with In Vivo Activity.	Array Biopharma
30455147	7	Discovery of covalent enzyme inhibitors using virtual docking of covalent fragments.	University of Houston
28105276	19	Covalent Guanosine Mimetic Inhibitors of G12C KRAS.	Dana Farber Cancer Institute
26230724	10	New Frontiers in Druggability.	Stony Brook University
23585920	11	Inhibition of Ras-Effector Interaction by Cyclic Peptides.	The Ohio State University
30258528	1	Precedence and Promise of Covalent Inhibitors of EGFR and KRAS for Patients with Non-Small-Cell Lung Cancer.	Pfizer
28740607	6	Crystal Structure of a Human K-Ras G12D Mutant in Complex with GDP and the Cyclic Inhibitory Peptide KRpep-2d.	Takeda Pharmaceutical
28457754	17	Investigation of the structural requirements of K-Ras(G12D) selective inhibitory peptide KRpep-2d using alanine scans and cysteine bridging.	Takeda Pharmaceutical